CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, we first coincubated FACS-purified CML stem/progenitor cells overnight with FACS-purified CD8+ CTLs derived from the same patients at an effector/target ratio of 1:1, followed by plating in methylcellulose.